Price controls and compulsory licences lead to double trouble in India Last week, an Indian panel of ministers proposed that that the government put all 348 drugs on the country’s National List of Essential Medicines under price control, including a number of patented drugs. The structur... By Peter Leung October 04 2012
MSF launches patent opposition database to aid pharmaceutical protestors Health activists who want to challenge patents given to drugs companies have been given a new tool to make the process easier By Managing IP Correspondent October 02 2012
